Ventricular premature contraction associated with mitral valve prolapse

Hong-TaoYuan, Mei Yang, Li Zhong, Ying Hsiang Lee, Vaibhav R. Vaidya, Samuel J Asirvatham, Michael John Ackerman, Sorin V. Pislaru, Rakesh M. Suri, Joshua P. Slusser, David O. Hodge, Yu Tang Wang, Yong-Mei Cha

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background In patients with frequent premature ventricular contractions (PVCs), little is known about the profile of PVCs and the outcome of treatment in patients with mitral valve prolapse (MVP) compared to those without MVP. Methods and results Patients with documented PVCs between January 2001 and October 2012 were divided into 2 groups: MVP and non-MVP. The PVC characteristics, efficacy of therapy, and outcome were compared between the 2 groups. A total of 112 patients with MVP and 952 without MVP were identified. The frequency of PVCs was similar between the 2 groups (P > .05). In patients who underwent cardiac mapping, PVCs originating in papillary muscles (26.7% vs 2.3%; P < .001) and fascicle (13.3% vs 3.4%; P < .001) were more frequently seen in the MVP group than in the non-MVP group, which raises the difficulty of catheter ablation. The 2 groups had similar response to catheter ablation or medical therapy (P > .05). The survival rate was similar between the 2 groups (P = .95). Conclusion In patients with significant PVC burden, MVP patients had similar PVC frequency, treatment outcome, and survival rate to those without MVP.

Original languageEnglish (US)
Pages (from-to)1144-1149
Number of pages6
JournalInternational Journal of Cardiology
Volume221
DOIs
StatePublished - Oct 15 2016

Fingerprint

Mitral Valve Prolapse
Ventricular Premature Complexes
Survival Rate
Papillary Muscles
Prolapse

Keywords

  • Antiarrhythmic drug
  • Mitral valve prolapse
  • Premature ventricular contraction
  • Radiofrequency catheter ablation

ASJC Scopus subject areas

  • Medicine(all)
  • Cardiology and Cardiovascular Medicine

Cite this

Ventricular premature contraction associated with mitral valve prolapse. / Hong-TaoYuan; Yang, Mei; Zhong, Li; Lee, Ying Hsiang; Vaidya, Vaibhav R.; Asirvatham, Samuel J; Ackerman, Michael John; Pislaru, Sorin V.; Suri, Rakesh M.; Slusser, Joshua P.; Hodge, David O.; Wang, Yu Tang; Cha, Yong-Mei.

In: International Journal of Cardiology, Vol. 221, 15.10.2016, p. 1144-1149.

Research output: Contribution to journalArticle

Hong-TaoYuan, Yang, M, Zhong, L, Lee, YH, Vaidya, VR, Asirvatham, SJ, Ackerman, MJ, Pislaru, SV, Suri, RM, Slusser, JP, Hodge, DO, Wang, YT & Cha, Y-M 2016, 'Ventricular premature contraction associated with mitral valve prolapse', International Journal of Cardiology, vol. 221, pp. 1144-1149. https://doi.org/10.1016/j.ijcard.2016.06.252
Hong-TaoYuan ; Yang, Mei ; Zhong, Li ; Lee, Ying Hsiang ; Vaidya, Vaibhav R. ; Asirvatham, Samuel J ; Ackerman, Michael John ; Pislaru, Sorin V. ; Suri, Rakesh M. ; Slusser, Joshua P. ; Hodge, David O. ; Wang, Yu Tang ; Cha, Yong-Mei. / Ventricular premature contraction associated with mitral valve prolapse. In: International Journal of Cardiology. 2016 ; Vol. 221. pp. 1144-1149.
@article{d98ae9fc533b4ca3935f2e71ab84b42b,
title = "Ventricular premature contraction associated with mitral valve prolapse",
abstract = "Background In patients with frequent premature ventricular contractions (PVCs), little is known about the profile of PVCs and the outcome of treatment in patients with mitral valve prolapse (MVP) compared to those without MVP. Methods and results Patients with documented PVCs between January 2001 and October 2012 were divided into 2 groups: MVP and non-MVP. The PVC characteristics, efficacy of therapy, and outcome were compared between the 2 groups. A total of 112 patients with MVP and 952 without MVP were identified. The frequency of PVCs was similar between the 2 groups (P > .05). In patients who underwent cardiac mapping, PVCs originating in papillary muscles (26.7{\%} vs 2.3{\%}; P < .001) and fascicle (13.3{\%} vs 3.4{\%}; P < .001) were more frequently seen in the MVP group than in the non-MVP group, which raises the difficulty of catheter ablation. The 2 groups had similar response to catheter ablation or medical therapy (P > .05). The survival rate was similar between the 2 groups (P = .95). Conclusion In patients with significant PVC burden, MVP patients had similar PVC frequency, treatment outcome, and survival rate to those without MVP.",
keywords = "Antiarrhythmic drug, Mitral valve prolapse, Premature ventricular contraction, Radiofrequency catheter ablation",
author = "Hong-TaoYuan and Mei Yang and Li Zhong and Lee, {Ying Hsiang} and Vaidya, {Vaibhav R.} and Asirvatham, {Samuel J} and Ackerman, {Michael John} and Pislaru, {Sorin V.} and Suri, {Rakesh M.} and Slusser, {Joshua P.} and Hodge, {David O.} and Wang, {Yu Tang} and Yong-Mei Cha",
year = "2016",
month = "10",
day = "15",
doi = "10.1016/j.ijcard.2016.06.252",
language = "English (US)",
volume = "221",
pages = "1144--1149",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Ventricular premature contraction associated with mitral valve prolapse

AU - Hong-TaoYuan,

AU - Yang, Mei

AU - Zhong, Li

AU - Lee, Ying Hsiang

AU - Vaidya, Vaibhav R.

AU - Asirvatham, Samuel J

AU - Ackerman, Michael John

AU - Pislaru, Sorin V.

AU - Suri, Rakesh M.

AU - Slusser, Joshua P.

AU - Hodge, David O.

AU - Wang, Yu Tang

AU - Cha, Yong-Mei

PY - 2016/10/15

Y1 - 2016/10/15

N2 - Background In patients with frequent premature ventricular contractions (PVCs), little is known about the profile of PVCs and the outcome of treatment in patients with mitral valve prolapse (MVP) compared to those without MVP. Methods and results Patients with documented PVCs between January 2001 and October 2012 were divided into 2 groups: MVP and non-MVP. The PVC characteristics, efficacy of therapy, and outcome were compared between the 2 groups. A total of 112 patients with MVP and 952 without MVP were identified. The frequency of PVCs was similar between the 2 groups (P > .05). In patients who underwent cardiac mapping, PVCs originating in papillary muscles (26.7% vs 2.3%; P < .001) and fascicle (13.3% vs 3.4%; P < .001) were more frequently seen in the MVP group than in the non-MVP group, which raises the difficulty of catheter ablation. The 2 groups had similar response to catheter ablation or medical therapy (P > .05). The survival rate was similar between the 2 groups (P = .95). Conclusion In patients with significant PVC burden, MVP patients had similar PVC frequency, treatment outcome, and survival rate to those without MVP.

AB - Background In patients with frequent premature ventricular contractions (PVCs), little is known about the profile of PVCs and the outcome of treatment in patients with mitral valve prolapse (MVP) compared to those without MVP. Methods and results Patients with documented PVCs between January 2001 and October 2012 were divided into 2 groups: MVP and non-MVP. The PVC characteristics, efficacy of therapy, and outcome were compared between the 2 groups. A total of 112 patients with MVP and 952 without MVP were identified. The frequency of PVCs was similar between the 2 groups (P > .05). In patients who underwent cardiac mapping, PVCs originating in papillary muscles (26.7% vs 2.3%; P < .001) and fascicle (13.3% vs 3.4%; P < .001) were more frequently seen in the MVP group than in the non-MVP group, which raises the difficulty of catheter ablation. The 2 groups had similar response to catheter ablation or medical therapy (P > .05). The survival rate was similar between the 2 groups (P = .95). Conclusion In patients with significant PVC burden, MVP patients had similar PVC frequency, treatment outcome, and survival rate to those without MVP.

KW - Antiarrhythmic drug

KW - Mitral valve prolapse

KW - Premature ventricular contraction

KW - Radiofrequency catheter ablation

UR - http://www.scopus.com/inward/record.url?scp=84981241206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981241206&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2016.06.252

DO - 10.1016/j.ijcard.2016.06.252

M3 - Article

C2 - 27522301

AN - SCOPUS:84981241206

VL - 221

SP - 1144

EP - 1149

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -